Ciplacef T 1000mg/125mg Injection
Marketer
Cipla Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ciplacef T 1000mg/125mg Injection
Cefixime and Sulbactam injection (1000mg/125mg) is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and spread. Administration must be solely under a doctor's guidance; strict adherence to the prescribed schedule is crucial. Complete the full course, regardless of symptom improvement, as premature cessation can compromise effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; severe reactions necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand prompt emergency care. Inform your physician about all concurrent medications, and pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occur. Adequate rest, nutritious food, and hydration are recommended for optimal recovery. Monitoring via laboratory tests may be employed to assess treatment efficacy.
Uses of Ciplacef T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ciplacef T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ciplacef T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ciplacef T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ciplacef T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam 1000mg/125mg (Ciplacef T) injection unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Ciplacef T 1000mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Ciplacef T (1000mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Ciplacef T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Ciplacef T 1000mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Operation of a motor vehicle is inadvisable should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ciplacef T 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ciplacef T 1000mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Ciplacef T 1000mg/125mg Injection dosage is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ciplacef T 1000mg/125mg Injection :
Omit a Ciplacef T 1000mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Ciplacef T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently